Vayarin™ is intended for the dietary management of Attention deficit hyperactivity disorder (ADHD). Vayarin™ contains Lipirinen, a proprietary composition containing Phosphatidylserine-Omega-3 EPA* enriched.
Phospholipids, such as phosphatidylserine (PS), are a class of lipids that serve as major building blocks for all cell membranes. PS, a vital phospholipid, plays an important role in the normal functioning of brain cells. Human brain cell membranes are highly enriched with PS, as compared to other tissues. Nerve cells in particular, depend on healthy membrane function for normal nerve signal transmission. PS levels in these tissues ensure membrane fluidity and structure. In fact, maintaining brain PS levels has been found to be associated with normal and efficient signal transduction processes, efficient glucose consumption and other biological pathways that are crucial for ensuring normal and healthy cognitive and mental functions.
Omega-3 fatty acids are polyunsaturated fatty acids that have been found to have unique and important health benefits. Several studies suggest that dietary consumption of omega-3, especially EPA and DHA, affect neuropsychiatric disorders, presumably due to their structural and neurochemical involvement in pathophysiological processes. As the evidence suggests, decreased levels of omega-3 fatty acids have been associated with several neuropsychiatric conditions, including ADHD. The results of VAYA Pharma’s clinical trial further support the beneficial effects of PS -omega-3 compound (Vayarin™) on children with ADHD symptoms.
*EPA- Eicosapentaenoic acid